Scientia Ventures

IntelinAir, Inc. is an aerial imagery analytics company based in San Jose, California, focused on providing technology solutions for the agriculture sector. Founded in 2014, the company specializes in delivering actionable intelligence from aerial data, enabling farmers to make data-driven decisions that enhance operational efficiency and increase crop yields. IntelinAir's SafeSmart technology offers precision flight and data analysis capabilities, with products including the SafeSmart RD-100 and RD-200 UAVs, which serve as flexible platforms for academic research and development. The company's interactive crop intelligence platform provides comprehensive field views, prioritizes monitoring needs, and facilitates timely reviews, empowering farmers and agricultural retailers to protect yield potential and identify sustainability opportunities throughout the growing season.

Humanity is a healthcare company founded in 2019 and headquartered in Boston, Massachusetts. It focuses on extending healthspan by developing a software application that provides users with information on interventions to mitigate the aging process. The application offers a subscription-based service that tracks key aging biomarkers, recovery, sleep duration, and activity levels. By analyzing this data, users can identify actions to slow aging and reduce the risk of related diseases. Through its innovative approach, Humanity aims to empower individuals to make informed decisions about their health and aging.

1910 Genetics is a biotechnology company focused on revolutionizing drug development through the integration of artificial intelligence, computation, and biological automation. The firm seeks to deepen the understanding of the molecular basis of diseases, akin to the comprehensive knowledge surrounding sickle cell anemia. By employing a multimodal AI platform, 1910 Genetics enhances the drug discovery process for both small and large molecules, providing a reimagined end-to-end approach. This innovative platform aims to improve productivity and reduce failure rates in pharmaceutical development, ultimately accelerating the design of therapeutics, including small molecules and proteins.

X-Vax Technology is a biotechnology company established in 2015 and headquartered in Jupiter, Florida. Its primary focus is the preclinical and clinical development of vaccines targeting mucosal infections caused by pathogens, including herpes, influenza, tuberculosis, and HIV, which affect millions globally. X-Vax is known for its development of a herpes vaccine candidate based on a genetically altered HSV-2 virus, specifically designed to elicit a robust immune response by inducing antibodies that lead to the killing of infected cells. This innovative approach utilizes Fc receptor activating antibodies that facilitate antibody-dependent cell-mediated killing, aiming to provide effective protection against herpes types 1 and 2. Through its pioneering research, X-Vax intends to advance the field of vaccines and enhance immune responses against significant viral infections.

DeepBiome Therapeutics Inc. is a biotechnology company focused on developing an innovative drug discovery platform that integrates microbiome research, deep learning, and synthetic biology. Founded in 2017 and based in Allston, Massachusetts, the company aims to address central nervous system disorders by translating complex microbiome data into actionable therapeutic insights. By harnessing the unique properties of the microbiome, DeepBiome Therapeutics enables pharmaceutical companies to explore novel therapeutic potentials, thereby enhancing drug development processes and improving treatment outcomes.

IntelinAir, Inc. is an aerial imagery analytics company based in San Jose, California, focused on providing technology solutions for the agriculture sector. Founded in 2014, the company specializes in delivering actionable intelligence from aerial data, enabling farmers to make data-driven decisions that enhance operational efficiency and increase crop yields. IntelinAir's SafeSmart technology offers precision flight and data analysis capabilities, with products including the SafeSmart RD-100 and RD-200 UAVs, which serve as flexible platforms for academic research and development. The company's interactive crop intelligence platform provides comprehensive field views, prioritizes monitoring needs, and facilitates timely reviews, empowering farmers and agricultural retailers to protect yield potential and identify sustainability opportunities throughout the growing season.

Drumroll AI is a data science platform that leverages artificial intelligence and advanced algorithms to enhance data analysis efficiency. The company's insight analytics engine is designed to automate, accelerate, and augment the process of extracting meaningful information from raw data. By automating data preparation tasks and query creation, Drumroll AI enables both data experts and non-experts to focus on deriving valuable insights from their data.

LiquiGlide Inc., founded in 2012 and based in Cambridge, Massachusetts, specializes in the development of innovative liquid-impregnated coatings designed to facilitate the effortless movement of viscous liquids. As a pioneer in creating permanently wet slippery surfaces, LiquiGlide provides unique solutions that enhance the flow of liquids across various industries, including manufacturing, oil and gas, aviation, utilities, and food and beverage. The company's technology addresses the common challenges associated with moving thick liquids, offering a durable alternative that is unmatched in the market. LiquiGlide's products are utilized in diverse applications, ranging from health and beauty to household goods, making it a versatile player in the coatings industry.

Cristcot Inc. is a Concord, Massachusetts-based company that specializes in developing and commercializing drug delivery systems to enhance patient care. Founded in 2008, Cristcot focuses on innovative solutions, notably its flagship product, Sephure, a disposable suppository applicator designed for the hygienic administration of both over-the-counter and prescription suppositories. This product addresses a range of medical conditions, including gastrointestinal diseases, spinal cord injuries, migraines, and various functional bowel disorders, while also supporting patients in end-of-life or palliative care. The company is committed to improving the ease and comfort of medication delivery, serving hospitals and healthcare providers, and providing its products online. Cristcot's pipeline also includes products aimed at addressing gastroenterology, neurology, and pain management.